Evidence map›Paper›PMID 41309631›Full record

ArticleNature communications2025

Molecular Motif Learning as a pretraining objective for molecular property prediction.

Ziyang Liu, Chaokun Wang, Shuwen Zheng, Cheng Wu, Hao Feng, Li Xu, Yue Zheng, Liang Rong, Peng Li

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ziyang LiuSchool of Software, Tsinghua University, Beijing, China.
Chaokun WangSchool of Software, Tsinghua University, Beijing, China. chaokun@tsinghua.edu.cn.ORCID 0000-0002-2986-2574
Shuwen ZhengSchool of Software, Tsinghua University, Beijing, China.
Cheng WuSchool of Software, Tsinghua University, Beijing, China.
Hao FengSchool of Software, Tsinghua University, Beijing, China.
Li XuTsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.
Yue ZhengTsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.
Liang RongTsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.
Peng LiTsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China. li-peng@mail.tsinghua.edu.cn.ORCID 0000-0002-8629-5246

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular property prediction is crucial for drug discovery in biopharmaceuticals since it helps identify promising compounds, optimizing the efficacy of developing new therapies. Despite its importance, existing deep learning-based methods for this task are often incongruous with fundamental chemical properties. Here we show that an unsupervised pretraining approach, Molecular Motif Learning (MotiL), learns molecular representations that preserve both whole-molecule structure and motif-level information directly from native molecular graphs. MotiL produces representations that group small molecules sharing a common core structure (i.e., scaffold) and proteins with related three-dimensional structures and functions. We evaluated MotiL on at least 16 molecule benchmarks, and uncovered that it captures analogous graph representations not only for small molecules with the same scaffold but also for protein macromolecules with similar structures and overlapping chemical functions such as tRNA binding. These informative representations empower MotiL to surpass the accuracy of state-of-the-art contrastive or predictive methods in the prediction of molecular properties like blood brain barrier permeability.

Indexed as

Deep LearningDrug DiscoveryProteinsBlood-Brain BarrierHumansModels, MolecularProteins

Identifiers

PMID41309631
PMCPMC12748552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.